Difference between revisions of "Team:Paris Bettencourt/Project/VitaminA"
Line 68: | Line 68: | ||
<br>The whole construct we designed was synthesized by IDT in 5 gBlocks. | <br>The whole construct we designed was synthesized by IDT in 5 gBlocks. | ||
<br><br><br><div align="center"><img src="https://static.igem.org/mediawiki/2015/5/52/ParisBettencourt_new_polycistron.jpg" width="500px"></img></div> | <br><br><br><div align="center"><img src="https://static.igem.org/mediawiki/2015/5/52/ParisBettencourt_new_polycistron.jpg" width="500px"></img></div> | ||
+ | |||
+ | <br><br> | ||
+ | <b>An optimized HMG gene</b> | ||
+ | <br>Additionally, we codon-optimized for <i>S. cerevisiae</i> the HMG-CoA reductase gene from <i>S. aureus</i> that had been used by Li & al. in 2013. Indeed, their study had shown that <i>S. cerevisiae</i> transformed with this gene had a better ß-carotene yield than the ones transformed by the tHMG1 from <i>S. cerevisiae</i>; it is highly probable than a codon-optimized version of this gene from <i>S. aureus</i> would produce even more ß-carotene. | ||
</div> | </div> | ||
Line 74: | Line 78: | ||
<br>In the strain containing the polycistron designed by Beekwilder, the polycistronic construct is on a plasmid (pUDC082). But since in our final product we would like our yeast to grow on non selective media and to keep the polycistron, we designed a way to integrate the construct in the yeast chromosome. Our plan was to use the HO-Poly-KanMX4-HO plasmid (AddGene plasmid #51662) as a backbone for our construct: it's a yeast plasmid for chromosomal integration into the HO locus, with a selection marker for yeast (KanMX4). This plasmid also has an origin of replication for <i>E. coli</i> and a selection marker for bacteria (Ampicillin). | <br>In the strain containing the polycistron designed by Beekwilder, the polycistronic construct is on a plasmid (pUDC082). But since in our final product we would like our yeast to grow on non selective media and to keep the polycistron, we designed a way to integrate the construct in the yeast chromosome. Our plan was to use the HO-Poly-KanMX4-HO plasmid (AddGene plasmid #51662) as a backbone for our construct: it's a yeast plasmid for chromosomal integration into the HO locus, with a selection marker for yeast (KanMX4). This plasmid also has an origin of replication for <i>E. coli</i> and a selection marker for bacteria (Ampicillin). | ||
− | <br><br>HO-Poly-KanMX4-HO plasmid | + | <br><br>Map of the HO-Poly-KanMX4-HO plasmid containing our optimized polycistron: |
<br> | <br> | ||
<div class="container content" ng-init="sample.size=375"> | <div class="container content" ng-init="sample.size=375"> | ||
Line 142: | Line 146: | ||
<br><br> | <br><br> | ||
− | <b> | + | <b>Mutation optimization</b> |
− | <br> | + | <br>Another very different way to improve the sequence of the pathway would be to replace the regions that are the most likely to mutate by alternative, more stable versions. Indeed, our strain is meant to be released in the environment without containment and to be consumed by people, so if mutations were to happen in the genes we have engineered, the yeast's ability to produce ß-carotene could be greatly reduced, or lost. Uncontrolled mutations could also have undesirable consequences which could be dangerous for the environment or for the consumers' health. |
+ | <br>To address this problem, we made a collaboration with the Vanderbilt iGEM Team 2015, who invented an algorithm to scan the sequences looking for regions that are likely to mutate. Thanks to their software they were able to find alternative versions of the crtE, crtI, crtYB and HMG-CoA genes that were more robust and durable. | ||
+ | |||
+ | |||
</div> | </div> | ||
<div style="clear:both"></div> | <div style="clear:both"></div> |
Revision as of 21:17, 18 September 2015